We have moved our website to embl.org/events. The content below is no longer being updated.
EMBL Courses and Conferences during the Coronavirus pandemic
With the onsite programme paused, many of our events are now being offered in virtual formats.
Registration is open as usual for many events, with back-up plans in place to move further courses and conferences online as necessary. Registration fees for any events affected by the COVID-19 disruption are fully refundable.
More information for participants of events at EMBL Heidelberg can be found here.
Despite the exciting advances in human genetics over the past decade, the fraction of the human proteome targeted by small molecules remains relatively small compared to the total number of genes linked to a disease phenotype by Mendelian inheritance or genome-wide association studies. Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology with three major themes:
- illuminating the druggable genome
- chemical interrogation of the druggable proteome
- new engineering approaches for breaking the druggability barrier
Co-organised with industry partners of the EMBL Corporate Partnership Programme, emphasis has been put on bringing together academic and industrial scientists with interests in chemical biology, chemogenomic libraries, pharmacology, medicinal chemistry and bioinformatics who have the curiosity and courage to challenge existing thinking and explore new ways of expanding the druggable proteome for better medicines.